文献速递炎症性肠病

溃疡性结肠炎患者中针对内皮蛋白C受体的新型诊断自身抗体

Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-12-28

该研究在日本和美国人群中分析炎症性肠病(IBD)患者及非IBD对照的血清样本,以明确抗内皮蛋白C受体(EPCR)抗体对IBD的诊断价值及其与疾病亚型和活动度的关系。背景提示该抗体在合并溃疡性结肠炎(UC)的Takayasu动脉炎患者中多见,且在无Takayasu动脉炎的UC患者中阳性率亦高。

要点

  • 抗EPCR抗体在合并UC的Takayasu动脉炎患者中多见,在无Takayasu动脉炎的UC患者中阳性率亦高。
  • 该研究旨在明确抗EPCR抗体对IBD的诊断价值及其与疾病亚型、活动度的关系。
  • 研究分析了日本和美国IBD患者及非IBD对照的血清样本。

核心结论

  • 抗EPCR抗体可能是有助于溃疡性结肠炎诊断的候选自身抗体。

研究设计与样本

  • 研究分析日本和美国的IBD患者及非IBD对照者的血清样本。

主要发现

  • 抗EPCR抗体在合并溃疡性结肠炎的Takayasu动脉炎患者中多见。
  • 无Takayasu动脉炎的溃疡性结肠炎患者中抗EPCR抗体阳性率亦高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There have been many reports on serologic autoantibodies in inflammatory bowel diseases (IBD),1 consisting of ulcerative colitis (UC) and Crohn's disease (CD), and recently Kuwada et al2 reported a new autoantibody against integrin αvβ6 with high sensitivity and specificity for UC. Concurrently, we had discovered autoantibodies against endothelial protein C receptor (EPCR) in Takayasu arteritis (TAK), which is sometimes complicated by UC.3 Interestingly, this autoantibody was found in most patients with TAK associated with UC, and we found that the positivity rate in patients with UC without TAK was also high, suggesting that anti-EPCR antibody is a candidate autoantibody useful for the diagnosis of UC.4 To clarify the diagnostic usefulness of anti-EPCR antibodies in patients with IBD and their relationship to several disease subphenotypes and their disease activities, we analyzed the serum samples from patients with IBD and non-IBD control subjects in Japan and the United States.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kakuta Y, Shirai T, McGovern DPB, et al. Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021. PMID: 34971808. doi:10.1016/j.cgh.2021.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。